FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 05:20:57 2024-07-11 am EDT | ||
| 0.39 EUR | 0.00% |
|
| Current month | -2.50% | ||
| 1 month | -13.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.39 | 0.00% |
| 24-07-10 | 0.39 | +2.63% |
| 24-07-09 | 0.38 | +8.57% |
| 24-07-08 | 0.35 | +2.94% |
| 24-07-05 | 0.34 | -5.56% |
Delayed Quote Deutsche Boerse AG
Last update July 11, 2024 at 05:20 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PE4BMY |
| ISIN | DE000PE4BMY1 |
| Date issued | 2022-04-07 |
| Strike | 41.12 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.46 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.01 € |
| Spread % | 2.50% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.12
USD
Average target price
53.1
USD
Spread / Average Target
+29.14%
- Stock Market
- Certificates
- Certificat
